Sudarshan Hebbar - Mar 20, 2023 Form 4 Insider Report for CalciMedica, Inc. /DE/ (CALC)

Signature
By John Dunn, Attorney-in-Fact
Stock symbol
CALC
Transactions as of
Mar 20, 2023
Transactions value $
$0
Form type
4
Date filed
3/22/2023, 08:48 PM
Next filing
May 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CALC Employee Stock Option (right to buy) Award +11.8K 11.8K Mar 20, 2023 Common Stock 11.8K $1.74 Direct F1, F2
transaction CALC Employee Stock Option (right to buy) Award +22.8K 22.8K Mar 20, 2023 Common Stock 22.8K $2.44 Direct F1, F3, F4
transaction CALC Employee Stock Option (right to buy) Award +8.64K 8.64K Mar 20, 2023 Common Stock 8.64K $2.44 Direct F1, F4, F5
transaction CALC Employee Stock Option (Right to Buy) Award +2.52K 2.52K Mar 20, 2023 Common Stock 2.52K $6.60 Direct F4, F6, F7
transaction CALC Employee Stock Option (right to buy) Award +25K 25K Mar 20, 2023 Common Stock 25K $6.60 Direct F4, F8, F9
transaction CALC Employee Stock Option (right to buy) Award +11.8K 11.8K Mar 20, 2023 Common Stock 11.8K $6.60 Direct F4, F10, F11
transaction CALC Employee Stock Option (right to buy) Award +9.77K 9.77K Mar 20, 2023 Common Stock 9.77K $7.99 Direct F4, F12, F13
transaction CALC Employee Stock Option (right to buy) Award +18.8K 18.8K Mar 20, 2023 Common Stock 18.8K $7.99 Direct F1, F4, F14
transaction CALC Employee Stock Option (right to buy) Award +9.77K 9.77K Mar 20, 2023 Common Stock 9.77K $7.99 Direct F4, F12, F13
transaction CALC Employee Stock Option (right to buy) Award +2.88K 2.88K Mar 20, 2023 Common Stock 2.88K $19.45 Direct F1, F4, F15
transaction CALC Employee Stock Option (right to buy) Award +838 838 Mar 20, 2023 Common Stock 838 $10.42 Direct F1, F4, F16
transaction CALC Employee Stock Option (right to buy) Award +1.95K 1.95K Mar 20, 2023 Common Stock 1.95K $10.42 Direct F1, F4, F17
transaction CALC Employee Stock Option (right to buy) Award +6.35K 6.35K Mar 20, 2023 Common Stock 6.35K $10.42 Direct F1, F4, F18
transaction CALC Employee Stock Option (right to buy) Award +23.8K 23.8K Mar 20, 2023 Common Stock 23.8K $17.34 Direct F4, F19, F20
transaction CALC Employee Stock Option (right to buy) Award +7.38K 7.38K Mar 20, 2023 Common Stock 7.38K $17.34 Direct F4, F19, F21
transaction CALC Employee Stock Option (right to buy) Award +3.11K 3.11K Mar 20, 2023 Common Stock 3.11K $17.34 Direct F4, F19, F22
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately exercisable.
F2 Received in exchange for a stock option to acquire 408,402 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc.
F3 Received in exchange for a stock option to acquire 790,880 shares of common stock of CalciMedica pursuant to the Merger Agreement.
F4 Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock.
F5 Received in exchange for a stock option to acquire 300,000 shares of common stock of CalciMedica pursuant to the Merger Agreement.
F6 25% of the shares subject to the option vested on April 30, 2020 and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments thereafter.
F7 Received in exchange for a stock option to acquire 87,658 shares of common stock of CalciMedica pursuant to the Merger Agreement.
F8 25% of the shares subject to the option vested on June 30, 2020 and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments thereafter.
F9 Received in exchange for a stock option to acquire 866,952 shares of common stock of CalciMedica pursuant to the Merger Agreement.
F10 25% of the shares subject to the option vested on January 1, 2021 and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments thereafter.
F11 Received in exchange for a stock option to acquire 408,982 shares of common stock of CalciMedica pursuant to the Merger Agreement.
F12 Beginning on February 22, 2021, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments.
F13 Received in exchange for a stock option to acquire 339,404 shares of common stock of CalciMedica pursuant to the Merger Agreement.
F14 Received in exchange for a stock option to acquire 652,174 shares of common stock of CalciMedica pursuant to the Merger Agreement.
F15 Received in exchange for a stock option to acquire 100,000 shares of common stock of CalciMedica pursuant to the Merger Agreement.
F16 Received in exchange for a stock option to acquire 29,117 shares of common stock of CalciMedica pursuant to the Merger Agreement.
F17 Received in exchange for a stock option to acquire 67,873 shares of common stock of CalciMedica pursuant to the Merger Agreement.
F18 Received in exchange for a stock option to acquire 220,588 shares of common stock of CalciMedica pursuant to the Merger Agreement.
F19 Beginning on November 22, 2022, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments.
F20 Received in exchange for a stock option to acquire 827,673 shares of common stock of CalciMedica pursuant to the Merger Agreement.
F21 Received in exchange for a stock option to acquire 256,287 shares of common stock of CalciMedica pursuant to the Merger Agreement.
F22 Received in exchange for a stock option to acquire 107,928 shares of common stock of CalciMedica pursuant to the Merger Agreement.